Rare diseases
Investigational molecules
Locations
239 conditions with trials, the busiest first
357 trials across Europe, recruiting first
Study on Oxaliplatin and Irinotecan for Patients with Metastatic Colorectal Cancer in the Liver
BelgiumStudy on Nivolumab with Drug Combination for Patients with Intermediate Stage Liver Cancer
FranceSafety and efficacy study of RTX001 autologous macrophage therapy in patients with decompensated liver cirrhosis
SpainStudy on Gemcitabine and Cisplatin for Patients After Surgery for Bile Duct or Gallbladder Cancer
AustriaStudy of Durvalumab and Tremelimumab for Patients with Resectable Liver Cancer
ItalyStudy on Bepirovirsen for Patients with Chronic Hepatitis B Receiving Nucleos(t)ide Analogue Treatment
BulgariaStudy on the Effects of VAY736 for Patients with Autoimmune Hepatitis Who Do Not Respond Well to Standard Treatment
CzechiaStudy on the Effects of Pariglasgene Brecaparvovec for Adults with Glycogen Storage Disease Type Ia
The NetherlandsLong-term Study on the Safety and Effectiveness of Odevixibat for Patients with Alagille Syndrome
BelgiumStudy on the Effectiveness and Safety of JNJ-73763989 and Tenofovir Alafenamide in Patients with Hepatitis B and D Co-infection
FranceStudy on the Effectiveness of Durvalumab and Bevacizumab with TACE in Patients with Localized Liver Cancer
FranceStudy of E7386 and Pembrolizumab for Patients with Previously Treated Colorectal Cancer, Melanoma, or Hepatocellular Carcinoma
SpainThe therapies tested most often in Hepatobiliary disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
